Wednesday, November 19, 2008 - 6:22PM EST

Clinical Trials

1. An off-the-shelf instant contact casting device for the management of diabetic foot ulcers: a randomized prospective trial versus traditional fiberglass cast.

Author
Piaggesi A; Macchiarini S; Rizzo L; Palumbo F; Tedeschi A; Nobili LA; Leporati E; Scire V; Teobaldi I; Del Prato S;
Institution
Section of Diabetes and Metabolic Diseases, Department of Endocrinology and Metabolism, University of Pisa and Azienda Ospedaliera Pisana, Pisa, Italy. piaggesi@immr.med.unipi.it
Journal
Diabetes Care. 2007 Mar;30(3):586-90.
Abstract URL
Click here to view abstract

2. Prospective randomized controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers.

Author
Jude EB; Apelqvist J; Spraul M; Martini J;
Institution
Department of Diabetic Medicine, Tameside General Hospital, Ashton-Under-Lyne, UK. edward.jude@tgh.nhs.uk
Journal
Diabet Med. 2007 Mar;24(3):280-8.
Abstract URL
Click here to view abstract

3. Negative pressure wound therapy via vacuum-assisted closure following partial foot amputation: what is the role of wound chronicity?

Author
Armstrong DG; Lavery LA; Boulton AJ;
Institution
Scholl's Center for Lower Extremity Ambulatory Research, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA. armstrong@usa.net
Journal
Int Wound J. 2007 Mar;4(1):79-86.
Abstract URL
Click here to view abstract

4. Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial.

Author
Lipsky BA; Sheehan P; Armstrong DG; Tice AD; Polis AB; Abramson MA;
Institution
Veterans Affairs Puget Sound Health Care System, University of Washington School of Medicine, Seattle, WA 98108-1597, USA. benjamin.lipsiy@med.va.gov
Journal
Int Wound J. 2007 Mar;4(1):30-8.
Abstract URL
Click here to view abstract

5. Preventing diabetic foot ulcer recurrence in high-risk patients: use of temperature monitoring as a self-assessment tool.

Author
Lavery LA; Higgins KR; Lanctot DR; Constantinides GP; Zamorano RG; Athanasiou KA; Armstrong DG; Agrawal CM;
Institution
Department of Surgery, Scott and White Hospital, Texas A&M University Health Science Center, Temple, Texas, USA. llavery@swmail.org
Journal
Diabetes Care. 2007 Jan;30(1):14-20.
Abstract URL
Click here to view abstract

6. Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study.

Author
Lyons TE; Miller MS; Serena T; Sheehan P; Lavery L; Kirsner RS; Armstrong DG; Reese A; Yankee EW; Veves A; Lyons TE; Miller MS; Serena T; Sheehan P; Lavery L; Kirsner RS; Armstrong DG; Reese A; Yankee EW; Veves A;
Institution
Beth Israel Deaconess Medical Center and Harvard Medical School, Palmer 321 A, West Campus, Boston, MA 02215, USA.
Journal
Am J Surg. 2007 Jan;193(1):49-54.
Abstract URL
Click here to view abstract

7. Does dermal thermometry predict clinical outcome in diabetic foot infection? Analysis of data from the SIDESTEP* trial.

Author
Armstrong DG; Lipsky BA; Polis AB; Abramson MA;
Institution
Rosalind Franklin University, Chicago, IL, USA. Armstrong@usa.net
Journal
Int Wound J. 2006 Dec;3(4):302-7.
Abstract URL
Click here to view abstract

8. Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers.

Author
Bowling FL; Salgami EV; Boulton AJ;
Institution
University Department of Medicine and Diabetes, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, U.K. frank.bowling@manchester.ac.uk
Journal
Diabetes Care. 2007 Feb;30(2):370-1.

9. Thrombin peptide Chrysalin stimulates healing of diabetic foot ulcers in a placebo-controlled phase I/II study.

Author
Fife C; Mader JT; Stone J; Brill L; Satterfield K; Norfleet A; Zwernemann A; Ryaby JT; Carney DH;
Institution
Department of Anesthesiology, University of Texas Health Science Center, Houston, Texas 77555-0645, USA.
Journal
Wound Repair Regen. 2007 Jan-Feb;15(1):23-34.
Abstract URL
Click here to view abstract

10. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers.

Author
Hanft JR; Pollak RA; Barbul A; van Gils C; Kwon PS; Gray SM; Lynch CJ; Semba CP; Breen TJ;
Institution
Doctor's Research Network, South Miami, Florida, USA.
Journal
J Wound Care. 2008 Jan;17(1):30-2, 34-7.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4